drugset / Trial / NCT00301613

Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN

NCT00301613

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is performed to compare the efficacy, safety, tolerability and relapse of MMF vs CTX in the treatment of severe HSPN

Timeline

Start
2003-01
Primary completion
2005-05
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mycophenolate Mofetil Small molecule 1 g